Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →

At a glance

Clients
1
past 12 months
Filings
1
last filed Jul 2026
Agencies
2
contacted · past 12 months
Activity
filings by quarter
Works on

Background

Career
Washington, DC
since at least 2024 - present
Dates reflect our filing record (begins 2024); many tenures start earlier.
Government experience
Senior Legislative Asst.
Cong. Earl Pomeroy
Disclosed on LD-2 filings

Specific issues

Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Medicare/Medicaid · 2024 Q4
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Taxation/Internal Revenue Code · 2024 Q4
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Trade (domestic/foreign) · 2024 Q4
Monitor legislative proposals relating to data privacy and security
Consumer Issues/Safety/Products · 2024 Q4
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Retirement · 2025 Q1
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Financial Institutions/Investments/Securities · 2025 Q1

Clients

2024 · 5 filings · engagement ended
$██,███ / qtrFree in beta
Past clients6
2024-2025 · 5 filings
$██,███ / qtrFree in beta
2024-2025 · 5 filings
$██,███ / qtrFree in beta
2024-2025 · 5 filings
$██,███ / qtrFree in beta
2024-2025 · 5 filings
$██,███ / qtrFree in beta
2024-2025 · 5 filings
$██,███ / qtrFree in beta

Filings · past 12 months

2024 Q4
BIOTECHNOLOGY INDUSTRY ORGANIZATION
4@lda.gov →
Older filings20
2025 Q1
PRUDENTIAL FINANCIAL INC
Q1lda.gov →
2025 Q1
INVESTMENT COMPANY INSTITUTE
Q1lda.gov →
2025 Q1
PRINCIPAL FINANCIAL GROUP
Q1lda.gov →
2025 Q1
NOVO NORDISK INC.
Q1lda.gov →
2025 Q1
ANHEUSER-BUSCH COMPANIES INC
Q1lda.gov →
2024 Q4
ANHEUSER-BUSCH COMPANIES INC
Q4lda.gov →
2024 Q4
PRINCIPAL FINANCIAL GROUP
Q4lda.gov →
2024 Q4
PRUDENTIAL FINANCIAL INC
Q4lda.gov →
2024 Q4
NOVO NORDISK INC.
Q4lda.gov →
2024 Q4
BIOTECHNOLOGY INDUSTRY ORGANIZATION
4Tlda.gov →
2024 Q4
INVESTMENT COMPANY INSTITUTE
Q4lda.gov →
2024 Q3
PRINCIPAL FINANCIAL GROUP
Q3lda.gov →
2024 Q3
INVESTMENT COMPANY INSTITUTE
Q3lda.gov →
2024 Q3
PRUDENTIAL FINANCIAL INC
Q3lda.gov →
2024 Q3
BIOTECHNOLOGY INDUSTRY ORGANIZATION
Q3lda.gov →
2024 Q3
NOVO NORDISK INC.
Q3lda.gov →
2024 Q3
ANHEUSER-BUSCH COMPANIES INC
Q3lda.gov →
2024 Q2
INVESTMENT COMPANY INSTITUTE
Q2lda.gov →
2024 Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q2lda.gov →
2024 Q2
ANHEUSER-BUSCH COMPANIES INC
Q2lda.gov →
Full record on lda.gov